These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2837785)

  • 1. Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber.
    Hanasawa K; Tani T; Oka T; Yoshioka T; Aoki H; Endo Y; Kodama M
    Prog Clin Biol Res; 1988; 264():337-41. PubMed ID: 2837785
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental study of extracorporeal perfusion for septic shock.
    Sato T; Orlowski JP; Zborowski M
    ASAIO J; 1993; 39(3):M790-3. PubMed ID: 8268646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mechanical assistance in the treatment of endotoxic and septicemic shock.
    Hanasawa K; Aoki H; Yoshioka T; Matsuda K; Tani T; Kodama M
    ASAIO Trans; 1989; 35(3):341-3. PubMed ID: 2557067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber.
    Hanasawa K; Tani T; Kodama M
    Surg Gynecol Obstet; 1989 Apr; 168(4):323-31. PubMed ID: 2538938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
    Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin apheresis for sepsis.
    Shimizu T; Endo Y; Tsuchihashi H; Akabori H; Yamamoto H; Tani T
    Transfus Apher Sci; 2006 Dec; 35(3):271-82. PubMed ID: 17118710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.
    Shoji H; Opal SM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T; Suzuki T; Kawagoe Y; Koide H
    ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock.
    Bende S; Bertók L
    Circ Shock; 1986; 19(2):239-44. PubMed ID: 3719924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of polymyxin B-immobilized fiber column in septic patients.
    Cruz DN; Bellomo R; Ronco C
    Contrib Nephrol; 2007; 156():444-51. PubMed ID: 17464156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
    Kanesaka S; Sasaki J; Kuzume M; Narihara K; Takahashi Y
    Int J Artif Organs; 2008 Oct; 31(10):891-7. PubMed ID: 19009507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood purification therapy for sepsis.
    Sakata H; Yonekawa M; Kawamura A
    Transfus Apher Sci; 2006 Dec; 35(3):245-51. PubMed ID: 17110167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic method against septic shock--removal of endotoxin using extracorporeal circulation.
    Kodama M; Hanasawa K; Tani T
    Adv Exp Med Biol; 1990; 256():653-64. PubMed ID: 2183569
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
    Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
    Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
    Shoji H; Tani T; Hanasawa K; Kodama M
    Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability of endotoxin adsorption during a longer duration of direct hemoperfusion with a polymyxin B-immobilized fiber column in patients with septic shock.
    Shimizu T; Obata T; Sonoda H; Akabori H; Tabata T; Eguchi Y; Endo Y; Tani T
    Transfus Apher Sci; 2013 Dec; 49(3):499-503. PubMed ID: 23683501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.